Exchange: NASDAQ·Updated 07:30 PM EDT

BLLN News

News
all
press releases
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.read more...
Benzinga
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.read more...
Benzinga
More News
BillionToOne SVP Sells 1,416 Shares
Key PointsThe transaction involved 1,416 shares at a weighted average price of $97.54 per share, totaling $138,116 on Sept. 9, 2026...
Nasdaq News: Markets
BillionToOne CEO Liquidates Entire Directly-Held Stake in the Company for $3 Million
Key PointsThe transaction involved 30,331 shares executed at a weighted average price of $99.91 per share on September 14, 2026...
Nasdaq News: Markets
BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference
BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference PR Newswire MENLO PARK, Calif., Sept. 2, 2026 MENLO PARK, Calif., Sept. 2, 2026 /PRNewswire/ -- BillionToOne, Inc. (NASDAQ: BLLN), a...
PR Newswire
BillionToOne's Co-Founder Sells 10,000 Shares for $1 Million
Key PointsThe transaction involved 10,000 shares at a weighted-average price of $100.00 per share, totaling $1.0 million on the August 25, 2026 transaction date...
Nasdaq News: Markets
Jim Cramer: 'You Could Make Some Money With This 5.6% Yield'
Jim Cramer likes Babcock & Wilcox and Smithfield Foods. He also advises taking some profits on BillionToOne, and calls Eton Pharma a winner.read more...
Benzinga
Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions
Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive...
PR Newswire
BillionToOne (BLLN) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
BillionToOne (BLLN) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for BillionToOne (BLLN) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
Does BillionToOne (BLLN) Have Another Major Growth Engine Beyond Prenatal Testing?
Does?BillionToOne?(BLLN) Have Another Major Growth Engine Beyond Prenatal Testing...
Yahoo! Finance: News

Advertisement|Remove ads.